More: 30th Annual San Antonio Breast Cancer Symposium (SABCS)

SABCS 2007: Improving Outcomes in Advanced and Metastatic Breast Cancer CME

December 13 - 16, 2007, San Antonio, Texas

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the San Antonio Breast Cancer Symposium.

Release Date: January 31, 2008; Valid for credit through January 31, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

  1. Current Front-line Treatment for Metastatic Breast CancerKathy D. Miller, MD
  2. Emerging Options for Treatment-Refractory Advanced Breast CancerLawrence N. Shulman, MD; Erica L. Mayer, MD, MPH
  3. Optimizing Treatment of "Triple-Negative" Breast CancerEric P. Winer, MD; Erica L. Mayer, MD, MPH

Legal Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the San Antonio Breast Cancer Symposium. These materials and the related activity are not sanctioned by the San Antonio Breast Cancer Symposium or the commercial supporter of the conference and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Roche, BMS
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe newly reported clinical studies and results of first-line treatment regimens for patients with advanced or metastatic breast cancer
  2. Explain challenges and resistance mechanisms in refractory advanced breast cancer and discuss new drugs and strategies developed to overcome resistance
  3. Evaluate the prognosis and treatment options for patients with triple-negative breast cancer
Authors and Disclosures

Erica L. Mayer, MD, MPH
Disclosure: Erica L. Mayer, MD, MPH, has disclosed that she has received grants for clinical research from AstraZeneca.


Kathy D. Miller, MD
Disclosure: Kathy D. Miller, MD, has disclosed that she has received grants for clinical research from EntreMed, Genentech, Pfizer, and Roche and has served as an advisor or consultant to Genentech and Roche.


Lawrence N. Shulman, MD
Disclosure: Lawrence N. Shulman, MD, has disclosed no relevant financial relationships.


Eric P. Winer, MD
Disclosure: Eric P. Winer, MD, has disclosed that he has received grants for clinical research from Aventis, Genentech, and GlaxoSmithKline and has served as an advisor or consultant to Genentech and GlaxoSmithKline.


Margie Miller
Disclosure: Margie Miller has disclosed no relevant financial relationships.


Jill W. Chamberlain
Disclosure: Jill W. Chamberlain has disclosed no relevant financial relationships.


Charlotte Warren
Disclosure: Charlotte Warren has disclosed no relevant financial relationships.


Shira Berman
Disclosure: Shira Berman has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.